SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ECV'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 769ASN A 770GLN A 776MET A 807ARG A 817LEU A 848CYH A 942THR A 945PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.68A | 1a28A-5mwpA:36.4 | 1a28A-5mwpA:46.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 769ASN A 770LEU A 772GLN A 776MET A 807ARG A 817CYH A 942THR A 945PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.42A | 1a28A-5mwpA:36.4 | 1a28A-5mwpA:46.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 769ASN A 770LEU A 772LEU A 938PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 ( 4.3A)ECV A1101 ( 4.7A) | 1.16A | 1a28A-5mwpA:36.4 | 1a28A-5mwpA:46.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772GLN A 776MET A 807ARG A 817MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.09A | 1a28A-5mwpA:36.4 | 1a28A-5mwpA:46.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 770GLN A 776MET A 807ARG A 817LEU A 848CYH A 942THR A 945 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.81A | 1a28B-5mwpA:36.5 | 1a28B-5mwpA:46.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772GLN A 776MET A 807ARG A 817CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.39A | 1a28B-5mwpA:36.5 | 1a28B-5mwpA:46.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772GLN A 776MET A 807ARG A 817MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.16A | 1a28B-5mwpA:36.5 | 1a28B-5mwpA:46.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1G50_A_ESTA600_1 (ESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 11 | LEU A 769LEU A 772ALA A 773ARG A 817MET A 845 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.55A | 1g50A-5mwpA:27.3 | 1g50A-5mwpA:16.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 769ASN A 770LEU A 772GLN A 776TRP A 806MET A 807MET A 845PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.7A) | 0.75A | 1gs4A-5mwpA:37.0 | 1gs4A-5mwpA:20.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GWR_A_ESTA600_1 (OESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 10 | LEU A 769LEU A 772ALA A 773LEU A 814ARG A 817 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.31A | 1gwrA-5mwpA:25.0 | 1gwrA-5mwpA:16.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 770GLN A 776TRP A 806MET A 807ARG A 817CYH A 942THR A 945PHE A 956LEU A 960 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A)None | 0.52A | 1m2zA-5mwpA:35.2 | 1m2zA-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLY A 774GLN A 776TRP A 806CYH A 942THR A 945PHE A 956LEU A 960 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A)None | 1.10A | 1m2zA-5mwpA:35.2 | 1m2zA-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776TRP A 806MET A 807ARG A 817MET A 852 | ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.27A | 1m2zA-5mwpA:35.2 | 1m2zA-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLN A 776MET A 807ARG A 817CYH A 942THR A 945PHE A 956LEU A 960 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A)None | 0.48A | 1m2zD-5mwpA:35.0 | 1m2zD-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 770GLY A 774GLN A 776CYH A 942THR A 945PHE A 956LEU A 960 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A)None | 1.12A | 1m2zD-5mwpA:35.0 | 1m2zD-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLN A 776LEU A 814ARG A 817MET A 852 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.34A | 1nhzA-5mwpA:28.8 | 1nhzA-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776LEU A 814ARG A 817MET A 852LEU A 938 | ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 1.30A | 1nhzA-5mwpA:28.8 | 1nhzA-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 769GLN A 776LEU A 814ARG A 817LEU A 938 | ECV A1101 (-4.7A)ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A) | 0.51A | 1nhzA-5mwpA:28.8 | 1nhzA-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 769ASN A 770LEU A 772GLN A 776MET A 807ARG A 817THR A 945 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.71A | 1p93A-5mwpA:34.0 | 1p93A-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772GLN A 776MET A 807ARG A 817MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.36A | 1p93A-5mwpA:34.0 | 1p93A-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLN A 776MET A 807LEU A 814ARG A 817CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.50A | 1p93B-5mwpA:34.3 | 1p93B-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.97A | 1p93B-5mwpA:34.3 | 1p93B-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776MET A 807LEU A 814ARG A 817MET A 852 | ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.27A | 1p93B-5mwpA:34.3 | 1p93B-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLN A 776MET A 807LEU A 814ARG A 817LEU A 938CYH A 942THR A 945 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.54A | 1p93C-5mwpA:33.8 | 1p93C-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774MET A 807CYH A 942THR A 945 | ECV A1101 (-3.1A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 1.21A | 1p93C-5mwpA:33.8 | 1p93C-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | GLN A 776MET A 807LEU A 814ARG A 817MET A 852LEU A 938 | ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 1.40A | 1p93C-5mwpA:33.8 | 1p93C-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLN A 776MET A 807ARG A 817PHE A 829CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.9A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.67A | 1p93D-5mwpA:33.9 | 1p93D-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.98A | 1p93D-5mwpA:33.9 | 1p93D-5mwpA:41.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QKN_A_RALA600_1 (ESTROGEN RECEPTORBETA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 769ALA A 773MET A 807LEU A 814ARG A 817 | ECV A1101 (-4.7A)ECV A1101 (-3.8A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.32A | 1qknA-5mwpA:24.6 | 1qknA-5mwpA:11.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QKT_A_ESTA600_1 (ESTRADIOL RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 10 | LEU A 769ALA A 773LEU A 814ARG A 817MET A 845 | ECV A1101 (-4.7A)ECV A1101 (-3.8A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.40A | 1qktA-5mwpA:23.8 | 1qktA-5mwpA:16.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_A_DESA459_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 766LEU A 769ALA A 773MET A 807ARG A 817 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.8A)ECV A1101 (-3.6A)ECV A1101 (-4.0A) | 0.56A | 1s9pA-5mwpA:26.9 | 1s9pA-5mwpA:16.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_B_DESB459_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 766LEU A 772ALA A 773MET A 807ARG A 817 | ECV A1101 ( 3.9A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-3.6A)ECV A1101 (-4.0A) | 0.62A | 1s9pB-5mwpA:27.2 | 1s9pB-5mwpA:16.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_C_DESC500_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 766LEU A 769LEU A 772ALA A 773MET A 807ARG A 817 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-3.6A)ECV A1101 (-4.0A) | 0.56A | 1s9pC-5mwpA:27.0 | 1s9pC-5mwpA:16.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_D_DESD600_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 766LEU A 769ALA A 773MET A 807ARG A 817 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.8A)ECV A1101 (-3.6A)ECV A1101 (-4.0A) | 0.50A | 1s9pD-5mwpA:28.7 | 1s9pD-5mwpA:16.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 766ASN A 770MET A 807LEU A 848CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 (-3.6A)NoneECV A1101 (-4.0A) | 0.93A | 1sqnA-5mwpA:36.2 | 1sqnA-5mwpA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772GLN A 776MET A 807CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A) | 0.48A | 1sqnA-5mwpA:36.2 | 1sqnA-5mwpA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 766ASN A 770GLN A 776MET A 807LEU A 848LEU A 938CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)NoneECV A1101 ( 4.3A)ECV A1101 (-4.0A) | 0.85A | 1sqnB-5mwpA:36.8 | 1sqnB-5mwpA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772GLN A 776MET A 807LEU A 938CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A) | 0.41A | 1sqnB-5mwpA:36.8 | 1sqnB-5mwpA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772LEU A 769LEU A 766LEU A 814LEU A 827 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-4.1A)None | 1.13A | 1sqnB-5mwpA:36.8 | 1sqnB-5mwpA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 765LEU A 772GLN A 776LEU A 814ARG A 817 | NoneECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 1.11A | 1ya3A-5mwpA:38.0 | 1ya3A-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 766ASN A 770LEU A 772ALA A 773GLN A 776MET A 807LEU A 814ARG A 817MET A 845CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.41A | 1ya3A-5mwpA:38.0 | 1ya3A-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 766ASN A 770LEU A 827CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A) | 1.32A | 1ya3A-5mwpA:38.0 | 1ya3A-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 772ALA A 773GLN A 776MET A 807LEU A 814ARG A 817MET A 852CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 (-4.0A) | 0.77A | 1ya3A-5mwpA:38.0 | 1ya3A-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | LEU A 766ASN A 770ALA A 773GLN A 776MET A 807SER A 811LEU A 814ARG A 817MET A 845LEU A 938CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-3.0A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.52A | 1ya3B-5mwpA:38.3 | 1ya3B-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 766ASN A 770LEU A 827CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A) | 1.26A | 1ya3B-5mwpA:38.3 | 1ya3B-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 766MET A 807SER A 810LEU A 814ARG A 817CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-3.6A)ECV A1101 (-3.4A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 1.48A | 1ya3B-5mwpA:38.3 | 1ya3B-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_C_STRC3001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772ALA A 773GLN A 776MET A 807ARG A 817MET A 845LEU A 938CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.54A | 1ya3C-5mwpA:38.1 | 1ya3C-5mwpA:73.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Z95_A_198A501_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772GLN A 776MET A 807ARG A 817ILE A 964 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)None | 0.64A | 1z95A-5mwpA:36.9 | 1z95A-5mwpA:18.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 10 | LEU A 766ASN A 770GLN A 776LEU A 814ARG A 817LEU A 848THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)NoneECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.76A | 1zucA-5mwpA:36.5 | 1zucA-5mwpA:46.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLN A 776MET A 807LEU A 814ARG A 817LEU A 848THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)NoneECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.71A | 1zucB-5mwpA:36.4 | 1zucB-5mwpA:46.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772GLN A 776MET A 807LEU A 814ARG A 817THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.44A | 1zucB-5mwpA:36.4 | 1zucB-5mwpA:46.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 766LEU A 769ASN A 770LEU A 827THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)NoneECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.29A | 1zucB-5mwpA:36.4 | 1zucB-5mwpA:46.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_A_STRA301_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | ASN A 770LEU A 772ALA A 773GLN A 776MET A 807SER A 810LEU A 814ARG A 817MET A 845CYH A 942THR A 945 | ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-3.4A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.47A | 2aa5A-5mwpA:39.7 | 2aa5A-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_A_STRA301_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 772ALA A 773GLN A 776MET A 807SER A 810LEU A 814ARG A 817MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-3.4A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 0.76A | 2aa5A-5mwpA:39.7 | 2aa5A-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 765LEU A 772GLN A 776LEU A 814ARG A 817 | NoneECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 1.29A | 2aa5B-5mwpA:39.3 | 2aa5B-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | LEU A 766ASN A 770LEU A 772ALA A 773GLN A 776MET A 807SER A 810LEU A 814ARG A 817MET A 845CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-3.4A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.50A | 2aa5B-5mwpA:39.3 | 2aa5B-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 766ASN A 770LEU A 827CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A) | 1.33A | 2aa5B-5mwpA:39.3 | 2aa5B-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_A_STRA401_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 769ASN A 770LEU A 772ALA A 773GLN A 776MET A 807LEU A 814ARG A 817MET A 845CYH A 942THR A 945 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.33A | 2aa6A-5mwpA:39.4 | 2aa6A-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_A_STRA401_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 769ASN A 770LEU A 827CYH A 942THR A 945 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A) | 1.39A | 2aa6A-5mwpA:39.4 | 2aa6A-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_A_STRA401_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 769LEU A 772ALA A 773GLN A 776MET A 807LEU A 814ARG A 817MET A 852CYH A 942 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 (-4.0A) | 0.68A | 2aa6A-5mwpA:39.4 | 2aa6A-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_B_STRB402_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | ASN A 770LEU A 772ALA A 773GLN A 776MET A 807LEU A 814ARG A 817MET A 845LEU A 938CYH A 942THR A 945 | ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.36A | 2aa6B-5mwpA:39.3 | 2aa6B-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_B_STRB402_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 772ALA A 773GLN A 776MET A 807LEU A 814ARG A 817MET A 852LEU A 938CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A) | 0.69A | 2aa6B-5mwpA:39.3 | 2aa6B-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ALA A 773GLN A 776MET A 807ARG A 817PHE A 829MET A 852CYH A 942 | ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.9A)ECV A1101 (-3.7A)ECV A1101 (-4.0A) | 0.75A | 2ab2A-5mwpA:39.4 | 2ab2A-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 766ASN A 770ALA A 773GLN A 776MET A 807ARG A 817PHE A 829MET A 845CYH A 942THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.9A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.38A | 2ab2A-5mwpA:39.4 | 2ab2A-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_2 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 6 | LEU A 769LEU A 772LEU A 814CYH A 849LEU A 938 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-4.1A)ECV A1101 (-3.8A)ECV A1101 ( 4.3A) | 0.20A | 2ab2A-5mwpA:39.4 | 2ab2A-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 770ALA A 773GLN A 776MET A 807ARG A 817PHE A 829MET A 852CYH A 942THR A 945 | ECV A1101 (-3.1A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.9A)ECV A1101 (-3.7A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.70A | 2ab2B-5mwpA:39.3 | 2ab2B-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 766ASN A 770ALA A 773GLN A 776MET A 807ARG A 817PHE A 829MET A 845CYH A 942THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.9A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.38A | 2ab2B-5mwpA:39.3 | 2ab2B-5mwpA:72.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_2 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 5 | LEU A 769LEU A 772LEU A 814CYH A 849 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-4.1A)ECV A1101 (-3.8A) | 0.21A | 2ab2B-5mwpA:39.3 | 2ab2B-5mwpA:72.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 770LEU A 772TRP A 806MET A 807ARG A 817MET A 845LEU A 938 | ECV A1101 (-3.1A)ECV A1101 ( 3.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A) | 0.72A | 2am9A-5mwpA:37.1 | 2am9A-5mwpA:20.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 765LEU A 772GLN A 776LEU A 814ARG A 817 | NoneECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 1.20A | 2oaxA-5mwpA:38.4 | 2oaxA-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | LEU A 766ASN A 770LEU A 772GLN A 776MET A 807LEU A 814ARG A 817MET A 845LEU A 938CYH A 942THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.51A | 2oaxA-5mwpA:38.4 | 2oaxA-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 766ASN A 770LEU A 827CYH A 942THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.18A | 2oaxA-5mwpA:38.4 | 2oaxA-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_2 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 5 | LEU A 769ALA A 773TRP A 806MET A 852 | ECV A1101 (-4.7A)ECV A1101 (-3.8A)NoneECV A1101 (-3.7A) | 0.64A | 2oaxA-5mwpA:38.4 | 2oaxA-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 765LEU A 772GLN A 776LEU A 814ARG A 817 | NoneECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 1.17A | 2oaxB-5mwpA:38.3 | 2oaxB-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | LEU A 766ASN A 770LEU A 772ALA A 773GLN A 776MET A 807LEU A 814ARG A 817LEU A 938CYH A 942THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.40A | 2oaxB-5mwpA:38.3 | 2oaxB-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 766ASN A 770LEU A 827CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A) | 1.28A | 2oaxB-5mwpA:38.3 | 2oaxB-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | LEU A 766ASN A 770ALA A 773GLN A 776TRP A 806MET A 807LEU A 814ARG A 817MET A 845LEU A 938THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.47A | 2oaxC-5mwpA:37.9 | 2oaxC-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 766ASN A 770LEU A 827THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)NoneECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.25A | 2oaxC-5mwpA:37.9 | 2oaxC-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | LEU A 766ASN A 770LEU A 772ALA A 773GLN A 776TRP A 806MET A 807LEU A 814ARG A 817MET A 845LEU A 938PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 ( 4.7A) | 0.43A | 2oaxD-5mwpA:38.6 | 2oaxD-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_2 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 5 | LEU A 769MET A 852CYH A 942THR A 945 | ECV A1101 (-4.7A)ECV A1101 (-3.7A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.80A | 2oaxD-5mwpA:38.6 | 2oaxD-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | LEU A 766ASN A 770LEU A 772ALA A 773GLN A 776MET A 807LEU A 814ARG A 817MET A 845LEU A 938CYH A 942PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 ( 4.7A) | 0.58A | 2oaxE-5mwpA:38.1 | 2oaxE-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 766ASN A 770LEU A 827CYH A 942PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 ( 4.7A) | 1.36A | 2oaxE-5mwpA:38.1 | 2oaxE-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | ASN A 770LEU A 772ALA A 773GLN A 776TRP A 806MET A 807LEU A 814ARG A 817LEU A 938CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.50A | 2oaxF-5mwpA:37.8 | 2oaxF-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770LEU A 827CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.15A | 2oaxF-5mwpA:37.8 | 2oaxF-5mwpA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_2 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 5 | LEU A 766LEU A 769MET A 845MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 0.77A | 2oaxF-5mwpA:37.8 | 2oaxF-5mwpA:73.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZ7_A_CA4A1_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 769ASN A 770LEU A 772GLN A 776ARG A 817MET A 845PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.7A) | 0.66A | 2oz7A-5mwpA:35.8 | 2oz7A-5mwpA:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 6 | TRP A 806MET A 807MET A 852LEU A 938 | NoneECV A1101 (-3.6A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 1.31A | 2oz7A-5mwpA:35.7 | 2oz7A-5mwpA:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q7I_A_TESA205_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 769ASN A 770LEU A 772GLN A 776MET A 807ARG A 817MET A 845 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.58A | 2q7iA-5mwpA:37.4 | 2q7iA-5mwpA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q7J_A_TESA203_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 766ASN A 770LEU A 772GLN A 776TRP A 806MET A 807ARG A 817MET A 845 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.67A | 2q7jA-5mwpA:37.4 | 2q7jA-5mwpA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q7K_A_TESA304_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 769ASN A 770LEU A 772GLN A 776MET A 807ARG A 817MET A 845LEU A 938 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A) | 0.64A | 2q7kA-5mwpA:37.3 | 2q7kA-5mwpA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774GLN A 776TRP A 806ARG A 817 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)NoneECV A1101 (-4.0A) | 1.44A | 2q7lA-5mwpA:37.2 | 2q7lA-5mwpA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 769ASN A 770LEU A 772GLN A 776TRP A 806MET A 807ARG A 817MET A 845 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.59A | 2q7lA-5mwpA:37.2 | 2q7lA-5mwpA:20.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 766GLN A 776TRP A 806MET A 807ARG A 817LEU A 848CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)NoneECV A1101 (-4.0A) | 0.95A | 2w8yA-5mwpA:36.4 | 2w8yA-5mwpA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 766LEU A 772GLN A 776TRP A 806MET A 807ARG A 817CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.61A | 2w8yA-5mwpA:36.4 | 2w8yA-5mwpA:40.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772GLN A 776MET A 807ARG A 817CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.49A | 2w8yB-5mwpA:36.4 | 2w8yB-5mwpA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772GLN A 776MET A 807ARG A 817MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.12A | 2w8yB-5mwpA:36.4 | 2w8yB-5mwpA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YHD_A_TESA1920_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 766ASN A 770LEU A 772GLN A 776MET A 807ARG A 817MET A 845 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.66A | 2yhdA-5mwpA:37.1 | 2yhdA-5mwpA:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 769ASN A 770LEU A 772MET A 807ARG A 817PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.7A) | 0.60A | 2yloA-5mwpA:37.0 | 2yloA-5mwpA:19.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YLP_A_TESA1921_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 11 | LEU A 766ASN A 770LEU A 772GLN A 776MET A 807ARG A 817LEU A 938 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A) | 0.69A | 2ylpA-5mwpA:37.3 | 2ylpA-5mwpA:19.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YLQ_A_TESA1921_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 11 | LEU A 766ASN A 770LEU A 772GLN A 776MET A 807ARG A 817 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A) | 0.65A | 2ylqA-5mwpA:37.2 | 2ylqA-5mwpA:19.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | ASN A 770GLN A 776MET A 807LEU A 814ARG A 817CYH A 849LEU A 938CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.8A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.49A | 3cldA-5mwpA:35.1 | 3cldA-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 770GLY A 774GLN A 776CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.18A | 3cldA-5mwpA:35.1 | 3cldA-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | ASN A 770GLN A 776MET A 807ARG A 817CYH A 849LEU A 938CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.8A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.54A | 3cldB-5mwpA:35.2 | 3cldB-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.86A | 3cldB-5mwpA:35.2 | 3cldB-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 766ASN A 770GLN A 776MET A 807ARG A 817LEU A 848CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)NoneECV A1101 (-4.0A) | 0.89A | 3d90A-5mwpA:35.7 | 3d90A-5mwpA:38.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772GLN A 776MET A 807ARG A 817CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.56A | 3d90A-5mwpA:35.7 | 3d90A-5mwpA:38.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772GLN A 776MET A 807ARG A 817MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.11A | 3d90A-5mwpA:35.7 | 3d90A-5mwpA:38.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 766LEU A 769ASN A 770GLN A 776MET A 807LEU A 814ARG A 817LEU A 848CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)NoneECV A1101 (-4.0A) | 0.78A | 3d90B-5mwpA:36.0 | 3d90B-5mwpA:38.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772GLN A 776MET A 807LEU A 814ARG A 817CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.59A | 3d90B-5mwpA:36.0 | 3d90B-5mwpA:38.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 772GLN A 776MET A 807LEU A 814ARG A 817MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.33A | 3d90B-5mwpA:36.0 | 3d90B-5mwpA:38.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ERD_A_DESA600_1 (ESTROGEN RECEPTORALPHA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 769ALA A 773LEU A 814ARG A 817MET A 845 | ECV A1101 (-4.7A)ECV A1101 (-3.8A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.52A | 3erdA-5mwpA:27.4 | 3erdA-5mwpA:13.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 770GLY A 774GLN A 776TRP A 806CYH A 942THR A 945VAL A 954 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)None | 1.15A | 3gn8A-5mwpA:36.1 | 3gn8A-5mwpA:42.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776TRP A 806MET A 807ARG A 817MET A 852 | ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.24A | 3gn8A-5mwpA:36.1 | 3gn8A-5mwpA:42.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 9 / 12 | LEU A 769ASN A 770GLN A 776TRP A 806MET A 807ARG A 817CYH A 942THR A 945VAL A 954 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)None | 0.41A | 3gn8A-5mwpA:36.1 | 3gn8A-5mwpA:42.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLY A 774GLN A 776TRP A 806CYH A 942THR A 945VAL A 954PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)NoneECV A1101 ( 4.7A) | 1.07A | 3gn8B-5mwpA:35.9 | 3gn8B-5mwpA:42.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776TRP A 806MET A 807ARG A 817MET A 852 | ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.21A | 3gn8B-5mwpA:35.9 | 3gn8B-5mwpA:42.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 10 / 12 | LEU A 769ASN A 770GLN A 776TRP A 806MET A 807ARG A 817CYH A 942THR A 945VAL A 954PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)NoneECV A1101 ( 4.7A) | 0.40A | 3gn8B-5mwpA:35.9 | 3gn8B-5mwpA:42.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776MET A 807ARG A 817MET A 852LEU A 938 | ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 1.35A | 3h52A-5mwpA:24.6 | 3h52A-5mwpA:53.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 769ASN A 770GLN A 776MET A 807ARG A 817LEU A 938 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A) | 0.73A | 3h52A-5mwpA:24.6 | 3h52A-5mwpA:53.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 10 | LEU A 772TRP A 806MET A 807MET A 959LEU A 960 | ECV A1101 ( 3.9A)NoneECV A1101 (-3.6A)NoneNone | 1.22A | 3h52B-5mwpA:26.6 | 3h52B-5mwpA:53.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776LEU A 814ARG A 817CYH A 849ILE A 964 | ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.8A)None | 1.07A | 3h52B-5mwpA:26.6 | 3h52B-5mwpA:53.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | GLY A 774GLN A 776LEU A 814ARG A 817CYH A 849CYH A 942ILE A 963 | NoneECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.8A)ECV A1101 (-4.0A)None | 0.92A | 3h52B-5mwpA:26.6 | 3h52B-5mwpA:53.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | GLN A 776TRP A 806MET A 807LEU A 814ARG A 817MET A 852 | ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.22A | 3h52C-5mwpA:25.2 | 3h52C-5mwpA:53.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | GLN A 776TRP A 806MET A 807LEU A 814ARG A 817PHE A 829 | ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 ( 4.9A) | 0.61A | 3h52C-5mwpA:25.2 | 3h52C-5mwpA:53.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | GLN A 776MET A 807LEU A 814ARG A 817LEU A 938CYH A 942 | ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A) | 0.79A | 3h52D-5mwpA:26.2 | 3h52D-5mwpA:53.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | GLN A 776MET A 807LEU A 814ARG A 817MET A 852LEU A 938 | ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 1.33A | 3h52D-5mwpA:26.2 | 3h52D-5mwpA:53.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 814ARG A 817MET A 845MET A 852LEU A 934 | ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)None | 1.32A | 3h52D-5mwpA:26.2 | 3h52D-5mwpA:53.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HM1_A_J3ZA2_1 (ESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 769ALA A 773LEU A 814ARG A 817MET A 845 | ECV A1101 (-4.7A)ECV A1101 (-3.8A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.48A | 3hm1A-5mwpA:28.3 | 3hm1A-5mwpA:14.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HM1_B_J3ZB1_1 (ESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 11 | LEU A 769LEU A 772LEU A 814ARG A 817MET A 845 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.41A | 3hm1B-5mwpA:28.0 | 3hm1B-5mwpA:14.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLN A 776TRP A 806MET A 807ARG A 817LEU A 938THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.46A | 3mneA-5mwpA:34.0 | 3mneA-5mwpA:47.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 770GLY A 774GLN A 776TRP A 806THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)NoneECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.28A | 3mneA-5mwpA:34.0 | 3mneA-5mwpA:47.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | GLN A 776TRP A 806MET A 807ARG A 817MET A 852LEU A 938 | ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 1.37A | 3mneA-5mwpA:34.0 | 3mneA-5mwpA:47.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLN A 776MET A 807ARG A 817LEU A 938CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.48A | 3mnoA-5mwpA:34.5 | 3mnoA-5mwpA:47.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 770GLY A 774GLN A 776MET A 807THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.20A | 3mnoA-5mwpA:34.5 | 3mnoA-5mwpA:47.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLN A 776MET A 807ARG A 817LEU A 938CYH A 942THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.49A | 3mnpA-5mwpA:35.1 | 3mnpA-5mwpA:47.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 770GLY A 774GLN A 776MET A 807THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.22A | 3mnpA-5mwpA:35.1 | 3mnpA-5mwpA:47.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLL_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 10 | LEU A 769LEU A 772MET A 807LEU A 814ARG A 817 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.38A | 3ollA-5mwpA:27.5 | 3ollA-5mwpA:14.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLS_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 769LEU A 772ALA A 773MET A 807LEU A 814ARG A 817 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.33A | 3olsA-5mwpA:28.2 | 3olsA-5mwpA:14.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLS_B_ESTB600_1 (ESTROGEN RECEPTORBETA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 769ALA A 773MET A 807LEU A 814ARG A 817 | ECV A1101 (-4.7A)ECV A1101 (-3.8A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.34A | 3olsB-5mwpA:27.5 | 3olsB-5mwpA:14.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 12 / 12 | LEU A 766ASN A 770ALA A 773GLN A 776MET A 807LEU A 814ARG A 817MET A 845LEU A 938CYH A 942THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.36A | 3vhuA-5mwpA:39.5 | 3vhuA-5mwpA:66.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 766ASN A 770LEU A 827CYH A 942THR A 945PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.26A | 3vhuA-5mwpA:39.5 | 3vhuA-5mwpA:66.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_2 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 5 | LEU A 769LEU A 772SER A 811MET A 852 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-3.0A)ECV A1101 (-3.7A) | 0.97A | 3vhuA-5mwpA:39.5 | 3vhuA-5mwpA:66.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZQT_A_TESA1000_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772MET A 807ARG A 817 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A) | 0.61A | 3zqtA-5mwpA:37.2 | 3zqtA-5mwpA:19.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_A_STRA301_1 (STEROID RECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772ALA A 773GLN A 776MET A 807ARG A 817MET A 845CYH A 942THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.46A | 4fn9A-5mwpA:37.6 | 4fn9A-5mwpA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_B_STRB301_1 (STEROID RECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772ALA A 773GLN A 776TRP A 806MET A 807ARG A 817MET A 845THR A 945 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.49A | 4fn9B-5mwpA:37.6 | 4fn9B-5mwpA:50.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774GLN A 776TRP A 806ARG A 817 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)NoneECV A1101 (-4.0A) | 1.50A | 4hlwA-5mwpA:37.3 | 4hlwA-5mwpA:19.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 769ASN A 770GLN A 776TRP A 806MET A 807ARG A 817 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A) | 0.66A | 4hlwA-5mwpA:37.3 | 4hlwA-5mwpA:19.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J24_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 769LEU A 772MET A 807LEU A 814ARG A 817 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.38A | 4j24A-5mwpA:28.3 | 4j24A-5mwpA:14.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J24_D_ESTD600_1 (ESTROGEN RECEPTORBETA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772ALA A 773MET A 807LEU A 814ARG A 817 | ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.31A | 4j24D-5mwpA:28.0 | 4j24D-5mwpA:14.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 9 | LEU A 766ALA A 844LEU A 848PHE A 941TYR A 944THR A 945LEU A 952 | ECV A1101 ( 3.9A)NoneNoneECV A1101 (-4.3A)NoneECV A1101 (-3.2A)None | 0.47A | 4ltwA-5mwpA:38.0 | 4ltwA-5mwpA:47.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_1 (ANCESTRAL STEROIDRECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 766LEU A 769ASN A 770LEU A 772ALA A 773GLN A 776MET A 807ARG A 817MET A 845LEU A 938CYH A 942 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A) | 0.44A | 4ltwA-5mwpA:38.0 | 4ltwA-5mwpA:47.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_2 (ANCESTRAL STEROIDRECEPTOR 2) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 8 | TRP A 806PHE A 941THR A 945VAL A 954PHE A 956 | NoneECV A1101 (-4.3A)ECV A1101 (-3.2A)NoneECV A1101 ( 4.7A) | 0.44A | 4ltwA-5mwpA:38.0 | 4ltwA-5mwpA:47.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OJB_A_198A1001_2 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 7 | ASN A 770MET A 852LEU A 938ILE A 963ILE A 964 | ECV A1101 (-3.1A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A)NoneNone | 0.76A | 4ojbA-5mwpA:36.8 | 4ojbA-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OJB_A_198A1001_2 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 7 | LEU A 769ASN A 770ILE A 963ILE A 964 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)NoneNone | 0.54A | 4ojbA-5mwpA:36.8 | 4ojbA-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OK1_A_198A1001_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 769LEU A 772GLN A 776MET A 807ARG A 817ILE A 964 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)None | 0.75A | 4ok1A-5mwpA:36.3 | 4ok1A-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OK1_A_198A1001_2 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 8 | ASN A 770MET A 852LEU A 938ILE A 963 | ECV A1101 (-3.1A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A)None | 0.77A | 4ok1A-5mwpA:36.3 | 4ok1A-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OK1_A_198A1001_2 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 8 | LEU A 766ASN A 770LEU A 938ILE A 963 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 ( 4.3A)None | 0.51A | 4ok1A-5mwpA:36.3 | 4ok1A-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OKB_A_198A1002_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772GLN A 776MET A 807ARG A 817ILE A 964 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)None | 0.74A | 4okbA-5mwpA:36.7 | 4okbA-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OKB_A_198A1002_2 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 6 | LEU A 769ASN A 770MET A 852LEU A 938 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 0.94A | 4okbA-5mwpA:36.7 | 4okbA-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OKT_A_198A1001_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 769LEU A 772GLN A 776MET A 807ARG A 817MET A 852ILE A 964 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)None | 0.92A | 4oktA-5mwpA:35.9 | 4oktA-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OKW_A_198A1001_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772GLN A 776MET A 807ARG A 817ILE A 964 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)None | 0.64A | 4okwA-5mwpA:36.8 | 4okwA-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OKX_A_198A1002_2 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 6 | LEU A 769ASN A 770MET A 852LEU A 938ILE A 964 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A)None | 0.87A | 4okxA-5mwpA:37.0 | 4okxA-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OLM_A_198A1001_1 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 769LEU A 772GLN A 776MET A 807ARG A 817 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A) | 0.65A | 4olmA-5mwpA:36.1 | 4olmA-5mwpA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OLM_A_198A1001_2 (ANDROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 6 | ASN A 770MET A 852ILE A 963ILE A 964 | ECV A1101 (-3.1A)ECV A1101 (-3.7A)NoneNone | 0.72A | 4olmA-5mwpA:36.1 | 4olmA-5mwpA:21.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774GLN A 776THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.24A | 4p6xA-5mwpA:34.9 | 4p6xA-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 769ASN A 770GLN A 776MET A 807LEU A 814ARG A 817THR A 945PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.56A | 4p6xA-5mwpA:34.9 | 4p6xA-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_C_HCYC900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 11 | ASN A 770LEU A 772GLN A 776TRP A 806MET A 807ARG A 817THR A 945 | ECV A1101 (-3.1A)ECV A1101 ( 3.9A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.2A) | 0.41A | 4p6xC-5mwpA:35.3 | 4p6xC-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 769ASN A 770GLN A 776MET A 807LEU A 814ARG A 817THR A 945PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.49A | 4p6xE-5mwpA:34.6 | 4p6xE-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | ASN A 770GLN A 776TRP A 806MET A 807LEU A 814ARG A 817THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.48A | 4p6xG-5mwpA:34.8 | 4p6xG-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774TRP A 806THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneNoneECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.02A | 4p6xG-5mwpA:34.8 | 4p6xG-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | GLN A 776TRP A 806MET A 807LEU A 814ARG A 817MET A 852 | ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.22A | 4p6xG-5mwpA:34.8 | 4p6xG-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774GLN A 776THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.29A | 4p6xI-5mwpA:34.9 | 4p6xI-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776MET A 807LEU A 814ARG A 817MET A 852 | ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.31A | 4p6xI-5mwpA:34.9 | 4p6xI-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 769ASN A 770GLN A 776MET A 807LEU A 814ARG A 817THR A 945PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.57A | 4p6xI-5mwpA:34.9 | 4p6xI-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 770GLN A 776TRP A 806MET A 807ARG A 817THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.45A | 4p6xK-5mwpA:35.2 | 4p6xK-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774TRP A 806THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneNoneECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.04A | 4p6xK-5mwpA:35.2 | 4p6xK-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776TRP A 806MET A 807ARG A 817MET A 852 | ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.29A | 4p6xK-5mwpA:35.2 | 4p6xK-5mwpA:45.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PXM_A_ESTA2000_1 (ESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 769LEU A 772ALA A 773LEU A 814ARG A 817 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.21A | 4pxmA-5mwpA:27.9 | 4pxmA-5mwpA:14.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ALA A 773GLN A 776MET A 807SER A 810ARG A 817MET A 852LEU A 938 | ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-3.4A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 0.93A | 4udaA-5mwpA:39.9 | 4udaA-5mwpA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 766ASN A 770ALA A 773GLN A 776MET A 807SER A 810ARG A 817MET A 845LEU A 938CYH A 942PHE A 956 | ECV A1101 ( 3.9A)ECV A1101 (-3.1A)ECV A1101 (-3.8A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-3.4A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A)ECV A1101 ( 4.7A) | 0.59A | 4udaA-5mwpA:39.9 | 4udaA-5mwpA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | ASN A 770GLY A 774GLN A 776TRP A 806THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)NoneECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.28A | 4udcA-5mwpA:35.0 | 4udcA-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776TRP A 806MET A 807ARG A 817MET A 852 | ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.24A | 4udcA-5mwpA:35.0 | 4udcA-5mwpA:41.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 769ASN A 770GLN A 776TRP A 806MET A 807ARG A 817THR A 945PHE A 956 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-2.9A)NoneECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.56A | 4udcA-5mwpA:35.0 | 4udcA-5mwpA:41.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772ALA A 773LEU A 814ARG A 817MET A 845 | ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.88A | 4xi3C-5mwpA:24.2 | 4xi3C-5mwpA:14.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772ALA A 773TRP A 806LEU A 814ARG A 817 | ECV A1101 ( 3.9A)ECV A1101 (-3.8A)NoneECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.58A | 4xi3C-5mwpA:24.2 | 4xi3C-5mwpA:14.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZN7_A_DESA601_1 (ESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 769ALA A 773LEU A 814ARG A 817MET A 845LEU A 960 | ECV A1101 (-4.7A)ECV A1101 (-3.8A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A)None | 0.62A | 4zn7A-5mwpA:27.5 | 4zn7A-5mwpA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GS4_A_ESTA603_1 (ESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772ALA A 773LEU A 814ARG A 817MET A 845 | ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.84A | 5gs4A-5mwpA:26.7 | 5gs4A-5mwpA:16.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GTR_A_ESTA601_1 (ESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | LEU A 772ALA A 773LEU A 814ARG A 817MET A 845 | ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.74A | 5gtrA-5mwpA:26.2 | 5gtrA-5mwpA:16.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HYR_B_ESTB601_1 (ESTROGEN RECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 11 | LEU A 772ALA A 773LEU A 814ARG A 817MET A 845 | ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-4.0A) | 0.49A | 5hyrB-5mwpA:26.9 | 5hyrB-5mwpA:11.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 766LEU A 769ASN A 770ALA A 773TRP A 806MET A 807SER A 810LEU A 814MET A 845MET A 852LEU A 938 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-3.8A)NoneECV A1101 (-3.6A)ECV A1101 (-3.4A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 0.42A | 5mwyA-5mwpA:43.2 | 5mwyA-5mwpA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 11 / 12 | LEU A 766LEU A 769ASN A 770ALA A 773TRP A 806MET A 807SER A 811LEU A 814MET A 845MET A 852LEU A 938 | ECV A1101 ( 3.9A)ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 (-3.8A)NoneECV A1101 (-3.6A)ECV A1101 (-3.0A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 0.42A | 5mwyA-5mwpA:43.2 | 5mwyA-5mwpA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 6 | GLN A 776ARG A 817PHE A 829CYH A 942THR A 945PHE A 956 | ECV A1101 (-2.9A)ECV A1101 (-4.0A)ECV A1101 ( 4.9A)ECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.27A | 5mwyA-5mwpA:43.2 | 5mwyA-5mwpA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 6 | PHE A 835CYH A 942THR A 945PHE A 956 | NoneECV A1101 (-4.0A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.14A | 5mwyA-5mwpA:43.2 | 5mwyA-5mwpA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 770GLN A 776MET A 807ARG A 817CYH A 849THR A 945PHE A 956 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.8A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 0.59A | 5nfpA-5mwpA:35.2 | 5nfpA-5mwpA:42.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | ASN A 770GLY A 774GLN A 776THR A 945PHE A 956 | ECV A1101 (-3.1A)NoneECV A1101 (-2.9A)ECV A1101 (-3.2A)ECV A1101 ( 4.7A) | 1.26A | 5nfpA-5mwpA:35.2 | 5nfpA-5mwpA:42.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776MET A 807ARG A 817CYH A 849MET A 852 | ECV A1101 (-2.9A)ECV A1101 (-3.6A)ECV A1101 (-4.0A)ECV A1101 (-3.8A)ECV A1101 (-3.7A) | 1.22A | 5nfpA-5mwpA:35.2 | 5nfpA-5mwpA:42.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TOA_A_ESTA601_1 (ESTROGEN RECEPTORBETA) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 769LEU A 772ALA A 773MET A 807LEU A 814ARG A 817 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)ECV A1101 (-3.8A)ECV A1101 (-3.6A)ECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.32A | 5toaA-5mwpA:25.6 | 5toaA-5mwpA:15.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 769LEU A 772GLY A 774GLN A 776LEU A 814ARG A 817CYH A 849 | ECV A1101 (-4.7A)ECV A1101 ( 3.9A)NoneECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.8A) | 0.81A | 5uc1A-5mwpA:22.9 | 5uc1A-5mwpA:43.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 772GLN A 776LEU A 814ARG A 817CYH A 849MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.8A)ECV A1101 (-3.7A) | 1.00A | 5uc1A-5mwpA:22.9 | 5uc1A-5mwpA:43.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 772GLN A 776TRP A 806LEU A 814ARG A 817MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)NoneECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.7A) | 1.22A | 5uc1A-5mwpA:22.9 | 5uc1A-5mwpA:43.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 772GLY A 774GLN A 776TRP A 806LEU A 814ARG A 817 | ECV A1101 ( 3.9A)NoneECV A1101 (-2.9A)NoneECV A1101 (-4.1A)ECV A1101 (-4.0A) | 0.80A | 5uc1A-5mwpA:22.9 | 5uc1A-5mwpA:43.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 8 / 12 | LEU A 769ASN A 770LEU A 772GLY A 774GLN A 776LEU A 814ARG A 817CYH A 849 | ECV A1101 (-4.7A)ECV A1101 (-3.1A)ECV A1101 ( 3.9A)NoneECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.8A) | 0.84A | 5uc1B-5mwpA:23.0 | 5uc1B-5mwpA:43.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 6 / 12 | LEU A 772GLN A 776LEU A 814ARG A 817CYH A 849MET A 852 | ECV A1101 ( 3.9A)ECV A1101 (-2.9A)ECV A1101 (-4.1A)ECV A1101 (-4.0A)ECV A1101 (-3.8A)ECV A1101 (-3.7A) | 0.98A | 5uc1B-5mwpA:23.0 | 5uc1B-5mwpA:43.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | ASN A 770GLN A 776TRP A 806ARG A 817PHE A 829LEU A 938CYH A 942 | ECV A1101 (-3.1A)ECV A1101 (-2.9A)NoneECV A1101 (-4.0A)ECV A1101 ( 4.9A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A) | 0.70A | 5uc3A-5mwpA:29.8 | 5uc3A-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776TRP A 806ARG A 817MET A 852LEU A 938 | ECV A1101 (-2.9A)NoneECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 1.27A | 5uc3A-5mwpA:29.8 | 5uc3A-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 5 / 12 | GLN A 776TRP A 806ARG A 817MET A 852LEU A 938 | ECV A1101 (-2.9A)NoneECV A1101 (-4.0A)ECV A1101 (-3.7A)ECV A1101 ( 4.3A) | 1.25A | 5uc3B-5mwpA:29.7 | 5uc3B-5mwpA:45.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
5mwp | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 7 / 12 | LEU A 769GLN A 776TRP A 806ARG A 817PHE A 829LEU A 938CYH A 942 | ECV A1101 (-4.7A)ECV A1101 (-2.9A)NoneECV A1101 (-4.0A)ECV A1101 ( 4.9A)ECV A1101 ( 4.3A)ECV A1101 (-4.0A) | 0.60A | 5uc3B-5mwpA:29.7 | 5uc3B-5mwpA:45.00 |